XENOSPIN
DEAD

Serial Number

76400436

Owner

AMERSHAM PLC

Attorney

Catherine Mennenga

Filing Date

Apr 30, 2002

Add to watchlist:

No watchlists yet
View on USPTO

XENOSPIN Trademark

Serial Number: 76400436 • Registration: 3089031

XENOSPIN is a trademark filed by AMERSHAM PLC on April 30, 2002. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

AMERSHAM PLC (44 trademarks)

BUCKINGHAMSHIRE HP7 9NA , GB

Entity Type: 03

GE HEALTHCARE LIMITED (94 trademarks)

AMERSHAM PLACE LITTLE CHALFONT
BUCKINGHAMSHIRE HP7 9NA , GB

Entity Type: 99

Trademark Details

Filing Date

April 30, 2002

Registration Date

May 9, 2006

Published for Opposition

April 26, 2005

Cancellation Date

December 14, 2012

Goods & Services

Educational services, namely training services and conducting classes and seminars in the field of medical imaging and diagnostics; holding seminars, conferences, symposiums and workshops relating to the pharmaceutical industry, for medical practitioners and employees of pharmaceutical companies

Scientific apparatus and instruments for use in measuring, monitoring and surveying, namely, computers, printers, and computer software programs for use in life science research and data analysis, namely, detecting and monitoring radiation, radioactivity, and radioactive contamination, and for nuclear cardiology and medical imaging, for use by laboratories; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films, namely, automated film readers and scanners; apparatus for electrophoresis comprised of gel separation units, power/control units, gel cassettes, tanks, and casting, running and blotting modules; chromatography columns and pumps; scientific apparatus for microfabrication comprised of scanners and imagers; apparatus for scintillation imaging cameras and scintillation counters; synthesis and purification intergrated systems comprised of chromatography monitors, computer hardware and data processing software for use in radiology; imaging apparatus for radioactive emissions for use in radiology; apparatus for use in the manufacturing of oligonucleotides, comprised of synthesizers and purifiers; apparatus for microarrays, comprised of array spotters, array scanners, slide processors and hybidation buffers; microvials, and microplates for scientific purposes; and parts and fittings for the aforesaid goods; diagnostic and test kits for non-medical purposes comprised of test tubes, test plates and indicator charts for evaluating test results

CHEMICALS, BIOCHEMICALS AND REAGENTS FOR USE IN INDUSTRY, SCIENCE, AND RESEARCH, NAMELY, NUCLEOTIDES, OLIGONUCLEOTIDES, PEPTIDES, PROTEINS, AMINO ACIDS, ORGANIC MOLECULES, CHEMICAL MARKERS FOR DNA AND RNA SYNTHESIS; REAGENTS FOR GENE EXPRESSION QUANTIFICATION; REAGENTS FOR USE WITH THE POLYMERASE REACTION, PCR, PROCESS AND RCA, ROLLING CIRCLE AMPLICATION PROCESS; REAGENTS FOR CDNA CLONING VECTORS, MODIFYING AND RESTRICTION ENZYMES; REAGENTS FOR LABELING, SEQUENCING AND FRAGMENT ANALYSIS OF NUCLEIC ACIDS, PROTEINS AND CUSTOM SYNTHESIS; REAGENTS FOR RECOMBINANT PROTEIN EXPRESSION PURIFICATION, CHROMATOGRAPHY MEDIA, ELECTROPHORESIS, SPECTROPHOTOMETRY AND FLUOROMETRY; RADIOCHEMICALS; SCINTILLATION ASSAYS; AND HIGH THROUGH PUT SCREENING ASSAYS FOR DRUG DEVELOPMENT; CHEMICAL PREPARATIONS AND SUBSTANCES FOR USE IN THE MANUFACTURE OF PHARMACEUTICAL PRODUCTS; DIAGNOSTIC PREPARATIONS AND SUBSTANCES FOR SCIENTIFIC AND RESEARCH USE; CHEMICAL TEST REAGENTS, SALINE SOLUTION AND REAGENT-COATED PAPER ALL FOR SCIENTIFIC AND LABORATORY USE; FISSIONABLE CHEMICAL ELEMENTS; RADIOACTIVE ELEMENTS, ISOTOPES, PREPARATIONS, AND REAGENTS FOR INDUSTRIAL, SCIENTIFIC, AND RESEARCH PURPOSES; KITS CONSISTING PRIMARILY OF CHEMICAL PREPARATIONS AND REAGENTS FOR ANALYSIS AND DIAGNOSIS USED FOR SCIENTIFIC PURPOSES, NAMELY, CELL SEPARATION AND CULTURE, NUCLEIC ACID PURIFICATION; RADIONUCLIDES; AND GASES AND GAS MIXTURES FOR INDUSTRIAL, SCIENTIFIC, AND RESEARCH PURPOSES; NONE OF THE FOREGOING FOR CLINICAL OR MEDICAL DIAGNOSTIC USE

PHARMACEUTICAL ADVICE AND CONSULTANCY SERVICES; PROVIDING MEDICAL INFORMATION; MEDICAL TESTING; MEDICAL IMAGING SERVICES; PROVIDING MEDICAL INFORMATION AND MEDICINAL INFORMATION, NAMELY, INFORMATION REGARDING PHARMACOLOGICAL PROPERTIES TO PHARMACEUTICAL COMPANIES AND MEDICAL PROFESSIONALS

Surgical, medical, dental, and veterinary apparatus and instruments used for the purpose of measuring, monitoring and surveying in the field of radiotherapy, namely, medical needles, suture needles, implantable radiation therapy devices and implantable radiation therapy devices consisting of encapulated radioisotope brachytherapy sources, radiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; radiological apparatus for diagnostic and medical purposes, namely, magnetic resonance imagers, MRI; x-ray apparatus for medical use; x-ray diagnostic apparatus, computerized tomography apparatus, cat scan apparatus; scanners and ultrasound diagnostic apparatus; cannulas; vial access cannulas; needles and syringes for medical use; injectors for medical use; cartridges for medical use; infusion pumps for intravenous administration of fluids; diagnostic and test kits for medical use comprised of test tubes, test plates and indicator charts for evaluating test results; and parts and fittings for the aforesaid goods

PHARMACEUTICAL ANALYSIS, NAMELY, CHEMICAL ANALYSIS AND PHARMACEUTICAL RESEARCH FOR PHARMACEUTICAL COMPANIES IN THE FIELD OF PURIFICATION AND CHROMATOGRAPHY; DEVELOPMENT SERVICES IN THE FIELDS OF PHARMACEUTICALS, LIFE SCIENCES, MEDICINE AND BIOCHEMISTRY; PRODUCT RESEARCH AND DEVELOPMENT FOR OTHERS, NAMELY RESEARCH AND DEVELOPMENT OF PHARMACEUTICAL, MEDICAL, AND VETERINARY PREPARATIONS, DIAGNOSTIC MEDIA AND AGENTS FOR USE IN MEDICAL AND DIAGNOSTIC IMAGING; MEDICAL LABORATORY SERVICES, NAMELY, MEDICAL DIAGNOSTIC SERVICES, AND MEDICAL IMAGING SERVICES; RADIOLABELING SERVICES, NAMELY ISOTOPIC LABELING OF BIOLOGICAL MOLECULES; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES FOR PHARMACEUTICAL COMPANIES AND MEDICAL PROFESSIONALS; AND CHEMICAL AND PHARMACEUTICAL RESEARCH FOR PHARMACEUTICAL COMPANIES IN THE FIELD OF PURIFICATION AND CHROMATOGRAPHY

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 14, 2012 C8..
REGISTERED-PRINCIPAL REGISTER
May 9, 2006 R.PR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Mar 10, 2006 ERRR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Feb 21, 2006 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
May 25, 2005 ETOF
PUBLISHED FOR OPPOSITION
Apr 26, 2005 PUBO
NOTICE OF PUBLICATION
Apr 6, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 7, 2005 PREV
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 12, 2005 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 12, 2005 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 30, 2004 CNSA
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 20, 2004 ETOP
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 14, 2004 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2004 TROA
NON-FINAL ACTION MAILED
Sep 15, 2004 CNRT
NON-FINAL ACTION WRITTEN
Sep 14, 2004 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 14, 2004 ZZZX
ASSIGNED TO LIE
Sep 1, 2004 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 24, 2004 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 24, 2004 ZZZX
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 23, 2004 ETOF
PUBLISHED FOR OPPOSITION
Jun 22, 2004 PUBO
PAPER RECEIVED
Jun 16, 2004 MAIL
NOTICE OF PUBLICATION
Jun 2, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2003 CNSA
CASE FILE IN TICRS
Sep 15, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2003 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 23, 2003 TROA
CONTINUATION OF FINAL REFUSAL MAILED
Aug 8, 2003 CNCF
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 29, 2003 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2003 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2003 CRFA
FINAL REFUSAL MAILED
Mar 13, 2003 CNFR
SEC. 44(E) CLAIM ADDED
Jan 10, 2003 44EA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2003 CRFA
PAPER RECEIVED
Jan 10, 2003 MAIL
ASSIGNED TO EXAMINER
Jan 3, 2003 DOCK
NON-FINAL ACTION MAILED
Oct 16, 2002 CNRT
ASSIGNED TO EXAMINER
Oct 15, 2002 DOCK
ASSIGNED TO EXAMINER
Aug 21, 2002 DOCK